David B. Frennesson,Piyasena Hewawasam,Omar D. Lopez,Van N. Nguyen,Mark G. Saulnier,Yong Tu,Alan Xiangdong Wang,Gan Wang,Ningning Xu,Roshan Yadavrao Nimje,Hasibur Rahaman,Samayamunthula Venkata Satya
申请号：
US15749557
公开号：
US20180221342A1
申请日:
2016.07.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
